Genmab | GEN - Cost Of Sales

Stock Price
1,694.00
Daily Change
4.00 0.24%
Monthly
-3.28%
Yearly
19.17%
Q2 Forecast
1,628.53

Genmab reported DKK81M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agios Pharmaceuticals USD 1.32M 560K Mar/2026
Almirall EUR 191.5M 2.29M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
Amgen USD 1.6B 187M Mar/2026
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 4.5B 194M Dec/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Demant DKK 2.89B 188M Dec/2025
Exelixis USD 26.48M 7.91M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GN Store Nord DKK 2.24B 338M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Insmed USD 46.16M 15.25M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
UCB EUR 1.07B 146M Dec/2025